Cargando…

GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice

OBJECTIVE: In addition to improve glucose intolerance, recent studies suggest that glucagon-like peptide-1 (GLP-1) receptor agonism also decreases triglyceride (TG) levels. The aim of this study was to evaluate the effect of GLP-1 receptor agonism on very-low-density lipoprotein (VLDL)-TG production...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parlevliet, Edwin T., Wang, Yanan, Geerling, Janine J., Schröder-Van der Elst, Janny P., Picha, Kristen, O'Neil, Karyn, Stojanovic-Susulic, Vedrana, Ort, Tatiana, Havekes, Louis M., Romijn, Johannes A., Pijl, Hanno, Rensen, Patrick C. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487842/ https://www.ncbi.nlm.nih.gov/pubmed/23133675 http://dx.doi.org/10.1371/journal.pone.0049152

Ejemplares similares

Acute Central Neuropeptide Y Administration Increases Food Intake but Does Not Affect Hepatic Very Low-Density Lipoprotein (Vldl) Production in Mice
por: Geerling, Janine J., et al.
Publicado: (2013)

GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance
por: Taher, Jennifer, et al.
Publicado: (2014)

Intracerebroventricular Administration of Neuropeptide Y Induces Hepatic Insulin Resistance via Sympathetic Innervation
por: van den Hoek, Anita M., et al.
Publicado: (2008)

Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice
por: Kooijman, Sander, et al.
Publicado: (2015)

Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol
por: Hodson, Leanne, et al.
Publicado: (2020)

Protein Engineering Strategies for Sustained Glucagon-Like Peptide-1 Receptor–Dependent Control of Glucose Homeostasis
por: Picha, Kristen M., et al.
Publicado: (2008)

SCFAs-Induced GLP-1 Secretion Links the Regulation of Gut Microbiome on Hepatic Lipogenesis in Chickens
por: Zhang, Jian-Mei, et al.
Publicado: (2019)

Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production
por: Yildirim, Vehpi, et al.
Publicado: (2023)

Both Transient and Continuous Corticosterone Excess Inhibit Atherosclerotic Plaque Formation in APOE*3-Leiden.CETP Mice
por: Auvinen, Hanna E., et al.
Publicado: (2013)

Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance
por: Roumans, Kay H. M., et al.
Publicado: (2020)

VLDL Hydrolysis by Hepatic Lipase Regulates PPARδ Transcriptional Responses
por: Brown, Jonathan D., et al.
Publicado: (2011)

ChREBP Rather Than SHP Regulates Hepatic VLDL Secretion
por: Niwa, Hiroyuki, et al.
Publicado: (2018)

Stimulatory Effect of Insulin on Glucose Uptake by Muscle Involves the Central Nervous System in Insulin-Sensitive Mice
por: Coomans, Claudia P., et al.
Publicado: (2011)

Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice
por: Ying, Zhixiong, et al.
Publicado: (2023)

Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion
por: van Zwol, Willemien, et al.
Publicado: (2023)

Decreases in the Serum VLDL-TG/Non-VLDL-TG Ratio from Early Stages of Chronic Hepatitis C: Alterations in TG-Rich Lipoprotein Levels
por: Nishimura, Motoi, et al.
Publicado: (2011)

Gene expressions of de novo hepatic lipogenesis in feline hepatic lipidosis
por: Valtolina, Chiara, et al.
Publicado: (2019)

Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis.
por: Boland, Michelle L., et al.
Publicado: (2020)

Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion
por: Sundaram, Meenakshi, et al.
Publicado: (2010)

A hierarchical dynamic model used for investigating feed efficiency and its relationship with hepatic gene expression in APOE*3‐Leiden.CETP mice
por: Zhang, Xiang, et al.
Publicado: (2021)

Glutathione deficiency down-regulates hepatic lipogenesis in rats
por: Brandsch, Corinna, et al.
Publicado: (2010)

Diphlorethohydroxycarmalol Attenuates Palmitate-Induced Hepatic Lipogenesis and Inflammation
por: Cha, Seon-Heui, et al.
Publicado: (2020)

Increased Hepatic Lipogenesis Elevates Liver Cholesterol Content
por: Berger, Jean-Mathieu, et al.
Publicado: (2021)

Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis
por: Uehara, Kahealani, et al.
Publicado: (2022)

RASAL2 Deficiency Attenuates Hepatic Steatosis by Promoting Hepatic VLDL Secretion via the AKT/TET1/MTTP Axis
por: Ding, Hao, et al.
Publicado: (2023)

Pharmacological Modulation of Dopamine Receptor D2-Mediated Transmission Alters the Metabolic Phenotype of Diet Induced Obese and Diet Resistant C57Bl6 Mice
por: de Leeuw van Weenen, J. E., et al.
Publicado: (2011)

IL-1 Signaling in Obesity-Induced Hepatic Lipogenesis and Steatosis
por: Negrin, Kimberly A., et al.
Publicado: (2014)

Regulation of hepatic lipogenesis by the zinc finger protein Zbtb20
por: Liu, Gan, et al.
Publicado: (2017)

Serine catabolism generates liver NADPH and supports hepatic lipogenesis
por: Zhang, Zhaoyue, et al.
Publicado: (2021)

The Effect of PPE-Induced Emphysema and Chronic LPS-Induced Pulmonary Inflammation on Atherosclerosis Development in APOE*3-LEIDEN Mice
por: Khedoe, P. Padmini S. J, et al.
Publicado: (2013)

Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets
por: Umpleby, A. Margot, et al.
Publicado: (2017)

Atherosclerosis-associated hepatic secretion of VLDL but not PCSK9 is dependent on cargo receptor protein Surf4
por: Wang, Bingxiang, et al.
Publicado: (2021)

VLDL-associated mutagenic activity.
por: Gomes, M. I., et al.
Publicado: (1982)

Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
por: Bruinstroop, Eveline, et al.
Publicado: (2012)

Plant Stanol Esters Lower Serum Triacylglycerol Concentrations via a Reduced Hepatic VLDL-1 Production
por: Plat, Jogchum, et al.
Publicado: (2009)

Hepatic Expression of the Serine Palmitoyltransferase Subunit Sptlc2 Reduces Lipid Droplets in the Liver by Activating VLDL Secretion
por: Kim, Goon-Tae, et al.
Publicado: (2020)

Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats
por: Luo, Fei, et al.
Publicado: (2021)

Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice
por: Cordoba-Chacon, Jose, et al.
Publicado: (2015)

Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling
por: Seo, Mi Hae, et al.
Publicado: (2016)

Sex Differences in Hepatic De Novo Lipogenesis with Acute Fructose Feeding
por: Low, Wee Suan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_04g9mjf9vgg2hkdhh7ieh8jd3l